These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17150311)

  • 21. Is autism a G-alpha protein defect reversible with natural vitamin A?
    Megson MN
    Med Hypotheses; 2000 Jun; 54(6):979-83. PubMed ID: 10867750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic treatment for the core deficits and associated symptoms of autism in children.
    West L; Waldrop J; Brunssen S
    J Pediatr Health Care; 2009; 23(2):75-89. PubMed ID: 19232924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A national profile of the health care experiences and family impact of autism spectrum disorder among children in the United States, 2005-2006.
    Kogan MD; Strickland BB; Blumberg SJ; Singh GK; Perrin JM; van Dyck PC
    Pediatrics; 2008 Dec; 122(6):e1149-58. PubMed ID: 19047216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker.
    Chrysostomou A; Pedagogos E; MacGregor L; Becker GJ
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):256-62. PubMed ID: 17699214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune and gastrointestinal dysfunctions: does a subset of children with autism reveal a broader connection?
    Brown AC; Mehl-Madrona L
    Expert Rev Gastroenterol Hepatol; 2011 Aug; 5(4):465-77. PubMed ID: 21780894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of female-pattern hair loss with spironolactone in a 9-year-old girl.
    Yazdabadi A; Green J; Sinclair R
    Australas J Dermatol; 2009 May; 50(2):113-4. PubMed ID: 19397563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of childhood autism spectrum disorders and loss of family income.
    Montes G; Halterman JS
    Pediatrics; 2008 Apr; 121(4):e821-6. PubMed ID: 18381511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin for insomnia in children with autism spectrum disorders.
    Andersen IM; Kaczmarska J; McGrew SG; Malow BA
    J Child Neurol; 2008 May; 23(5):482-5. PubMed ID: 18182647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum anti-myelin-associated glycoprotein antibodies in Egyptian autistic children.
    Mostafa GA; El-Sayed ZA; El-Aziz MM; El-Sayed MF
    J Child Neurol; 2008 Dec; 23(12):1413-8. PubMed ID: 19073846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prenatal, perinatal, and neonatal factors associated with autism spectrum disorders.
    Bilder D; Pinborough-Zimmerman J; Miller J; McMahon W
    Pediatrics; 2009 May; 123(5):1293-300. PubMed ID: 19403494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?
    Bansal S; Lindenfeld J; Schrier RW
    Circ Heart Fail; 2009 Jul; 2(4):370-6. PubMed ID: 19808361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of hormonal therapy for female pattern (androgenic) alopecia.
    Scheinfeld N
    Dermatol Online J; 2008 Mar; 14(3):1. PubMed ID: 18627703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of genomeceuticals to the molecular and immunological aspects of autism.
    Brudnak MA
    Med Hypotheses; 2001 Aug; 57(2):186-91. PubMed ID: 11461171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spironolactone and risk of upper gastrointestinal events: spironolactone may not be guilty.
    Campbell E; Shonde A; Foley S
    BMJ; 2006 Sep; 333(7566):500; author reply 500-1. PubMed ID: 16946346
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological treatment options for autism spectrum disorders in children and adolescents.
    Leskovec TJ; Rowles BM; Findling RL
    Harv Rev Psychiatry; 2008; 16(2):97-112. PubMed ID: 18415882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spironolactone has antiarrhythmic activity in ischaemic cardiac patients without cardiac failure.
    Shah NC; Pringle SD; Donnan PT; Struthers AD
    J Hypertens; 2007 Nov; 25(11):2345-51. PubMed ID: 17921831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrointestinal symptoms in children with an autism spectrum disorder and language regression.
    Valicenti-McDermott MD; McVicar K; Cohen HJ; Wershil BK; Shinnar S
    Pediatr Neurol; 2008 Dec; 39(6):392-8. PubMed ID: 19027584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Children with autism spectrum disorders and intellectual disability.
    McCarthy J
    Curr Opin Psychiatry; 2007 Sep; 20(5):472-6. PubMed ID: 17762590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term low-dose spironolactone therapy is safe in oligoanuric hemodialysis patients.
    Matsumoto Y; Kageyama S; Yakushigawa T; Arihara K; Sugiyama T; Mori Y; Sugiyama H; Ohmura H; Shio N
    Cardiology; 2009; 114(1):32-8. PubMed ID: 19342857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.